 Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, et al.
Cytochrome p-450 polymorphisms in response to clopidogrel. N Engl
J Med 2009;360:354-62.
148. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W,
Gottlieb S, et al. Prasugrel versus clopidogrel in patients with acute
coronary syndromes. N Engl J Med 2007;357:2001-15.
149. De Miguel A, Ibanez B, Badim√≥n JJ. Clinical implications of clopidogrel resistance. Thromb Haemost 2008;100:196-203.
150. Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, et
al. A comparison of warfarin and aspirin for the prevention of recurrent
ischemic stroke. N Engl J Med 2001;345:1444-51.
151. ESPRIT Study Group, Halkes PH, van Gijn J, Kappelle LJ, Koudstaal
PJ, Algra A. Medium intensity anticoagulation vs. aspirin after cerebral
ischemia or arterial origin (ESPRIT): a randomized controlled trial.
Lancet Neurol 2007;6:6115-24.
152. Nair A, Sealove B, Halperin JL, Webber G, Fuster V. Anticoagulation
in patients with heart failure: who, when, and why? Eur Heart J Suppl
2006;8(suppl E):E32-8.
153. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, et al. ACC/AHA 2007 Guidelines on Perioperative cardiovascular Evaluation and care for Noncardiac Surgery: a Report of the
American College of Cardiology/American Heart Association Task
Force on Practice Guidelines (Writing Committee to